Pfizer Inc. (PFE) — Analyst outlook / Analyst consensus target is. Based on 39 analyst ratings, the consensus is bullish — 16 Buy, 22 Hold, 1 Sell.
The consensus price target is $27.50 (low: $24.00, high: $35.00), representing an upside of 1.4% from the current price $27.13.
Analysts estimate Earnings Per Share (EPS) of $2.93 and revenue of $63.08B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $1.42 vs est $2.93 (missed -51.5%). 2025: actual $1.36 vs est $3.12 (missed -56.4%). Analyst accuracy: 0%.
PFE Stock — 12-Month Price Forecast
$27.50
▲ +1.36% Upside
Average Price Target
Based on 39 Wall Street analysts offering 12-month price targets for Pfizer Inc., the average price target is $27.50, with a high forecast of $35.00, and a low forecast of $24.00.
The average price target represents a +1.36% change from the last price of $27.13.
Highest Price Target
$35.00
Average Price Target
$27.50
Lowest Price Target
$24.00
PFE Analyst Ratings
Hold
Based on 39 analysts giving stock ratings to Pfizer Inc. in the past 3 months
EPS Estimates — PFE
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $1.42
vs Est $2.93
▼ 106.1% off
2025
Actual $1.36
vs Est $3.12
▼ 129.4% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — PFE
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $63.627B
vs Est $63.083B
▲ 0.9% off
2025
Actual $62.579B
vs Est $61.936B
▲ 1.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
